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1. Introduction 
Glycerol phosphate dehydrogenase (GPDH) and 
~utamine synthetase are both localized in glial cells 
of the central nervous system [ 1,2]. Moreover, both 
enzymes are induced by hydrocortisone (HC) in C6 
glioma cells, and both inductions require de novo 
RNA and protein synthesis [3,4]. In a variety of cell 
types, sodium butyrate (NaB) is a potent inducer of 
differentiation, enzyme activity and new gene expres- 
sion [5,7]. Since NaB also interacts with GPDH 
induction in glial cells [S] as well as with other 
HC-mediated enzyme inductions in different cell 
types (91, we are continuing to utilize this short-chain 
fatty acid to clarify the mechanisms by which gluco- 
corticoids regulate gene expression in brain cells. 
We have reported that 5 mM NaB completely 
inhibits the HC-mediated rise in GPDH activity in 
both C6 glioma and primary cultures of oligodendro- 
cytes [8]. This inhibition is reversible and is not the 
result of NaB-induced non-specific toxicity. Further- 
more, NaB does not inactivate either basal or induced 
GPDH molecules. We have also shown that the HC 
induction of GPDH is mediated by the classical ster- 
oid-receptor complex and is solely due to an increase 
in the rate of synthesis of the enzyme [9,10]. To 
investigate the nature of the inhibition of this induc- 
tion by NaB, we measured the rate of synthesis of 
newly made GPDH molecules and examined the 
effect of NaB upon another glucocorticoid-inducible 
enzyme in C6 cells, glutamine synthetase (GS). We 
now report a novel finding. By itself, NaB induces 
GS. However, in combination with HC, NaB has no 
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secondary effects upon the HC-mediated induction of 
GS. This lack of effect contrasts with our earlier 
report of a complete block of the WC induction of 
GPDH. 
2. Materials and methods 
C6 glioma cells are a clonal cell line originally 
derived from rat neural tumor induced by N-nitro- 
metliylurea [ 111. Cells were cultured and maintained 
as in [8]. 
Glutamine synthetase was determined by a radio- 
chemical assay [4]. Protein was determined on the 
cytosol fraction [ 121. The rate of synthesis of GPDH 
under various treatment conditions was determined 
by immunoprecipitation and SDS gel electrophoresis 
as in [lo]. 
3. Results and discussion 
Treatment of C6 glioma cells with 5 mM NaB 
results in a 3-4-fold increase in GS activity after 24 h 
(fig.1). In combination with 1.38 PM NC, the response 
is equal to the sum of the enzyme activities (above 
basal level) induced by NaB and HC individually 
(fig.1). Actinomycin D (1 pg/ml) and cycloheximide 
(30 MM) abolished the NaB-mediated induction, while 
0.1 /*g/ml actinomycin D was ineffective (not shown). 
Thus, NaB, like HC, requires RNA and protein syn- 
thesis in order to induce GS. That the antiglucocor- 
ticoid progesterone (10 FM) inhibits the HC-mediated 
induction of GS activity (fig.l), but not that of NaB, 
suggests that these agents induce GS by partially dif- 
ferent mechanisms. The dose-response curve of the 
NaB induction of GS is bell-shaped (fig.2) with a 
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Fig.1. Confluent C6 glioma cells grown on Falcon plastic 
25 cm2 flasks were induced for 24 h under the various freat- 
ment conditions as shown. Cells were harvested, and gluta- 
mine synthetase activity is determined. HC was 1.38 PM; 
NaB, 5 mM; progesterone (Prop), 10 PM. The values expressed 
are av. 3 flasks I SD. The experiment was repeated 3 times. 
maximum at l-5 mM NaB. Doses as low as 0.1 mM 
NaB result in small, but significant increases in GS 
activity. 
While it is clear that NaB affects at least one of the 
steps of the HC induction of GPDH, it appears that 
NaB has absolutely no effect on the HC induction of 
glutamine synthetase. We base this conclusion on the 
following: By itself, 5 mM NaB yields a maximal GS 
response (fig.2), while 1.38 MM IX, by itself, repre- 
sents a saturating concentration in terms of optimum 
GS induction in C6 cells [13]. I-Ienee, if NaB has a 
secondary effect upon the HC-mediated induction, 
one would not obtain an additive GS response when 
C6 cells are exposed to these two agents simulta- 
neously. However, this is not the case. Induced 
enzyme levels are indeed additive (fig.1). 
This differential action of NaB on GS YS GPDH, 
combined with the observation that progesterone fails 
to inhibit the NaB induction of GS while profoundly 
in~biting that of HCI suggests that NaB does not 
interact with glucocorticoid steroid receptors. We had 
reported the absence of a NaB effect upon cytoplas- 
mic steroid binding in C6 cells [8]. Moreover, if any 
other steps by which the steroid-hormone complex 
exerts its biological effects in C6 cells are impaired by 
NaB, then one should expect i~ibition of HC-induc- 
ible proteins other than GPDH. Since NaB does not 
inhibit ~utami~e synthetase induction by HC, it 
appears that the NaB inhibition specific to GPDH 
induction occurs at those steps of its induction (that 
it does not share with GS induction) distal to the 
~u~~orticoid-receptor complex reaching the 
nucleus. Our observation of a total inhibition in the 
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Fig.2. Confluent C6 glioma cells grown on Falcon plastic 
25 cm2 flasks were treated with various [ NaB] for 24 h. Cells 
were then harvested and glutamine synthetase activity deter- 
mined. Glutamine synthetase activity is expressed as nmol 
glutamine mine’. mg protein-‘. The values expressed are av. 
3 flasks i SD. The experiment was repeated 2 times. 
induced increase in GPDH synthesis by NaB (table 1) 
also supports the notion of a nuclear site of inhibi- 
tion. The extent of this i~ibition correlates we11 with 
the complete inhibition of induced enzyme activity. 
Further investigation of the step(s) of GPDH induc- 
tion uniquely i~libited by NaB should provide us 
with a more specific understanding of the molecular 
mechanisms of hormone action. 
In searching for a mechanism at the nuclear level 
to explain NaB’s varied actions on these two enzymes, 
the well-known massive histone hyperacetylation by 
NaB in mammalian cells 114,161 is currently a fruit- 
ful area of research. It has been postulated that his- 
tone acetylation correlates with gene activation [l I]. 
The observed NaB induction of GS is in accord with 
this theory. Nevertheless, it remains to be seen 
whether the amount of enzyme induction correlates 
with the extent of histone modification. NaB at 
0.5 mM (fig.21 yields nearly maximal GS induction, 
while recent studies of histone hyperacetylation 
[14,16] employed higher doses (I-10 mM). In this 
regard the less than maximal GS levels with >S mM 
NaB is perplexing, though non-specific toxicity at 
these higher concentrations is a real possibility. 
Among the gene products thus far investigated, 
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Table 1 
The relative rates of synthesis of GPDH in response to WC and NaB and, their 
combined action 
April 1981 
Units~GPD~ 
mg protein 
cpm in GPDH Total cpm %Relativc rate of 
__._____ -1___- GPDH synthesis 
mg protein mg protein 
Control 117 474 1809 892 0.026 
NaB 105 261 I 744 767 0.015 
HC 324 4967 2 182 797 0.228 
Na3 + HC 120 335 1696 970 0.020 
The relative rate of synthesis of GPDH in C6 glioma cells expressed as cpm specifi- 
cally incorporated into GPDH relative to the total cpm incorporated into protein. 
Cells were pulsed for 1 h with 5 tiCi/ml [3H]leucine 23 h after the addition of the 
various treatment conditions, where HC was 1.38 yM and NaB was 5 mM. One unit 
of GPDH activity is expressed as that amount which oxidizes I nmbl NaOH/min 
at 30°C 
increases in their relative rates of syntheses by Na3 
seem to be the general rule [6,14,163. Thus our origi- 
nal observation of i~bition by NaB of the HC 
induction of GPDH appears exceptional. Since its 
publication, a stri~n~y similar il~~bitioli by NaB of 
estradiol’s induction of ovalbumin and transferrin in 
oviduct has been reported [ 18). In this case the site 
of inhibition is transcriptional, the estradiol-receptor 
system is unaffected, and the extent of inhibition 
correlates with the extent of histone acetylation by 
various other inhibitory short-chain fatty acids. 
However, the differential sensitivities of GPDH 
and GS to sodium butyrate as demonstrated by their 
dose--response curves may be indicative of separate 
mechanisms by which NaB acts to inhibit HC-medi- 
ated GPDH induction and to induce GS. Whereas 
0.1 mM NaB is ineffective in blocking GPDH induc- 
tion /8], this concentration is sufficient for GS induc- 
tion (fig.2). Thus, at present a single mechanism such 
as histone hyperacetylation does not appear to 
account for NaB’s diversity of effects in C6 cells. 
With respect to giiai cells as target tissues for gluco- 
corticoids, only future research will indicate whether 
these differential actions of NaB on glucocorticoid- 
mediated enzyme inductions are unique to g&I cells 
or represent a more widespread cellular phenomenon, 
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